Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Quinidine sulfate dihydrate

Base Information
  • Chemical Name:Quinidine sulfate dihydrate
  • CAS No.:6591-63-5
  • Deprecated CAS:60553-86-8
  • Molecular Formula:2C20H24N2O2*8H2O*H2O4S
  • Molecular Weight:891.047
  • Hs Code.:2939200050
  • European Community (EC) Number:200-046-3,678-472-8
  • UNII:J13S2394HE
  • DSSTox Substance ID:DTXSID101017271
  • Wikidata:Q27281012
  • NCI Thesaurus Code:C48014
  • RXCUI:9069
  • Pharos Ligand ID:FVG9PYTL7D4N
  • ChEMBL ID:CHEMBL3707183
  • Mol file:6591-63-5.mol
Quinidine sulfate dihydrate

Synonyms:(S)-[(4S,5R,7R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol sulfate dihydrate

Suppliers and Price of Quinidine sulfate dihydrate
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Quinidine Sulfate
  • 1g
  • $ 403.00
  • TRC
  • Quinidinesulfatedihydrate
  • 2.5g
  • $ 45.00
  • TRC
  • Quinidinesulfatedihydrate
  • 25g
  • $ 175.00
  • Sigma-Aldrich
  • Quinidine sulfate European Pharmacopoeia (EP) Reference Standard
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 25g
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate European Pharmacopoeia (EP) Reference Standard
  • q0100000
  • $ 190.00
  • Sigma-Aldrich
  • Quinidine sulfate United States Pharmacopeia (USP) Reference Standard
  • 500mg
  • $ 366.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 50g
  • $ 349.00
  • Sigma-Aldrich
  • Quinidine sulfate salt dihydrate
  • 10g
  • $ 88.80
  • Medical Isotopes, Inc.
  • QuinidineSulfateDihydrate
  • 1 g
  • $ 610.00
Total 59 raw suppliers
Chemical Property of Quinidine sulfate dihydrate
Chemical Property:
  • Appearance/Colour:white to light yellow crystal powde 
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:212-214 ºC (dec.) 
  • Refractive Index:275 ° (C=2, 0.1mol/L HCl) 
  • Boiling Point:992.5°C at 760 mmHg 
  • Flash Point:554°C 
  • PSA:192.62000 
  • LogP:6.52160 
  • Storage Temp.:under inert gas (nitrogen or Argon) at 2-8°C 
  • Sensitive.:Light Sensitive 
  • Solubility.:Slightly soluble in water, soluble in boiling water and in ethanol (96 per cent), practically insoluble in acetone. 
  • Water Solubility.:Soluble in chloroform, water (11 mg/ml at 20°C), alcohol, and ethanol (50 mg/ml). 
  • Hydrogen Bond Donor Count:6
  • Hydrogen Bond Acceptor Count:14
  • Rotatable Bond Count:8
  • Exact Mass:782.35606511
  • Heavy Atom Count:55
  • Complexity:538
Purity/Quality:

98%,99%, *data from raw suppliers

Quinidine Sulfate *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes:Xn 
  • Statements: 22-20/21/22 
  • Safety Statements: 13-36 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.OS(=O)(=O)O
  • Isomeric SMILES:COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.O.O.OS(=O)(=O)O
  • Recent ClinicalTrials:Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
  • Recent NIPH Clinical Trials:Quinidine sulfate administration for intractable epilepsy with KCNT1 gene mutation
  • Uses Quinidine sulfate dihydrate (cas# 6591-63-5) is the hydrated, sulfate salt of Quinidine (Q685000), a dextrorotatory stereoisomer of Quinine. Antiarrhythmic (class IA). Antimalarial.
  • Clinical Use Quinidine sulfate is the prototype of antiarrhythmicdrugs and a class IA antiarrhythmic agent according to theVaughan Williams classification. It reduces Na+ current bybinding the open ion channels (i.e., state A). The decreasedNa+entry into the myocardial cell depresses phase 4 diastolicdepolarization and shifts the intracellular threshold potentialtoward zero. These combined actions diminish thespontaneous frequency of pacemaker tissues, depress theautomaticity of ectopic foci, and, to a lesser extent, reduceimpulse formation in the SA node. This last action results inbradycardia. During the spike action potential, quinidinesulfate decreases transmembrane permeability to passiveinflux of Na+, thus slowing the process of phase 0 depolarization,which decreases conduction velocity. This is shownas a prolongation of the QRS complex of electrocardiograms.Quinidine sulfate also prolongs action potential duration,which results in a proportionate increase in the QTinterval. It is used to treat supraventricular and ventricularectopic arrhythmias, such as atrial and ventricular prematurebeats, atrial and ventricular tachycardia, atrial flutter, andatrial fibrillation.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6591-63-5